Key result
Primary percutaneous coronary intervention for STEMI in patients aged 80 years or older was associated with higher 1-year mortality compared to patients under 60 years.
Why the study?
Does increasing age worsen clinical outcomes in STEMI patients undergoing primary percutaneous coronary intervention?
Observational (n=434)
No
Does increasing age worsen clinical outcomes in STEMI patients undergoing primary percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Very elderly patients (≥80 years) undergoing primary PCI for STEMI have significantly higher in-hospital and 1-year mortality compared to younger patients, strongly influenced by cardiogenic shock and less frequent use of adjunctive therapies like glycoprotein IIb/IIIa inhibitors.
BACKGROUND: Primary percutaneous intervention (PPCI) is the treatment of choice for ST elevation myocardial infarction (STEMI) but robust evidence in the very elderly is lacking. We compared PPCI outcomes between different age quartiles (quartile 1 < 60 years, quartile 2 ≥ 60 to < 70 years, quartile 3 ≥ 70 to < 80 years, quartile 4 ≥ 80 years). METHODS: Retrospective observational analysis of our Morriston Tertiary Cardiac Center (Abertawe Bro Morgannwg University Health Board) patients from 2005 to 2010 with STEMI who underwent PPCI. RESULTS: Of 434 patients, 57 (13%) were in quartile 4 (≥ 80 years). In older age quartiles, patients were less likely to receive a drug eluting stent (DES, P = 0.001) or glycoprotein IIb/IIIa inhibitor (GPI, P < 0.0001). Increase in age was associated with reduced time to survival (β-coefficient: -0.192, t: -3.70, 95%CI: -4.91 to -1.50, P < 0.0001) as was the presence of cardiogenic shock (β-coefficient: -0.194, t = 3.77, 95%CI: -5.26 to -1.65, P < 0.0001). Use of GPI was associated with increased time to survival (β-coefficient: 0.138, t = 2.82, 95%CI: 1.58-8.58, P = 0.005) but older age quartiles were less likely to receive GPI (P < 0.0001). In-hospital mortality (1.8% quartile 1, 3.6% quartile 2, 10.9% quartile 3 and 12.3% quartile 4, P = 0.002) and 1-year mortality (5.4% quartile 1, 5.5% quartile 2, 16.8% quartile 3 and 24.6% quartile 4, P < 0.0001, respectively) was significantly higher in older age quartiles. CONCLUSIONS: Increased short term and intermediate term mortality is seen in the very elderly after PPCI. Age and cardiogenic shock were prognostic factors. Intervention should not be based on age alone and awareness regarding prognostic factors can help improve management.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2015) conducted an observational in ST elevation myocardial infarction (STEMI) (n=434). Primary percutaneous coronary intervention (PPCI) in older age (≥80 years) vs. PPCI in younger age (<60 years) was evaluated on 1-year all-cause mortality (p=<0.0001). Primary percutaneous coronary intervention for STEMI in patients aged 80 years or older was associated with higher 1-year mortality compared to patients under 60 years.
Synapse has enriched 10 related papers. Consider them for comparative context: